Your question is in relation to the mandate and the work of the Patented Medicine Prices Review Board. Unfortunately, I'm not in a position to comment on what information is made available to the board when making their price determinations.
As you may know, Mr. Davies, they sit at arm's length to the department. They're quasi-judicial. We don't have a view into the information that they receive. Officials from the board would be better placed to respond to your question.